MPM BioVentures 2014, L.P. - Insider Trading & Ownership

Entity
Company
Location
C/O Mpm Asset Management Llc, 450 Kendall Street, Cambridge, MA
Summary
The estimated value of insider holdings of MPM BioVentures 2014, L.P. is at least $93.7M dollars as of June 5, 2023. MPM BioVentures 2014, L.P. is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $70.8M. MPM BioVentures 2014, L.P. is the 10%+ Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $22.9M.
All Insider Reports
All Insider Reports

Ownership of MPM BioVentures 2014, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. 10%+ Owner $70.8M Nov 2, 2021
ITOS iTeos Therapeutics, Inc. 10%+ Owner $22.9M Jan 4, 2022
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner Jun 1, 2023

Insider Transactions Reported by MPM BioVentures 2014, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.